The TOGETHER Project - Kidney RNA-seq Validation

The researchers are trying to develop a way to measure the risk of rejection through the validation of a blood test.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Transplant Rejection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic, Scottsdale, Arizona, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult (>/=18 years) renal transplant recipient.
Patients who have given informed consent and are willing to comply with the protocol, including the use of their peripheral blood specimens and data for subsequent research.

Exclusion criteria

-Adult (<18 years) renal transplant recipient.

Treatment and study plan

Primary outcomes

To validate the use of a RNA-seq based peripheral blood assay in renal transplant recipients.

Time frame: 3 years

The study will validate the ability of a peripheral blood assay to assess the risk of biopsy proven rejection.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients-RNA-seq Signature Validation

Acronym: TOGETHER

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2019
First posted: Mar 14, 2019
Registry last updated: Sep 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed